ISSN 2306-5559 (print)
ISSN 2410-938X (online)
ISSN 2410-938X (online)
The authors declare that they have no potential conflicts of interest that require disclosure in this article.
Semova, I. (2021). Triglycerides in nonalcoholic fatty liver disease: Guilty until proven innocent. Trends in Pharmacological Sciences, 42(3), 183–190.Fan, N. (2019). Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: A cross-sectional study. Lipids in Health and Disease, 18, 1–6.Bril, F. (2017). Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology, 65(4), 1132–1144.Zhang, S. (2017). The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids in Health and Disease, 16, 1–8.Xing, J. (2021). Triglycerides mediate body mass index and nonalcoholic fatty liver disease: A population-based study. Obesity Facts, 14(2), 190–196.Hou, X. (2021). A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test. Lipids in Health and Disease, 20(1), 54.Ling, Q. (2023). The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose–response meta-analysis. Frontiers in Endocrinology, 13, 1043169.Kitae, A. (2019). The triglyceride and glucose index is a predictor of incident nonalcoholic fatty liver disease: A population-based cohort study. Canadian Journal of Gastroenterology and Hepatology, 2019(1), 5121574.Wang, R. (2021). Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: Insights from a general population. Lipids in Health and Disease, 20, 1–11.Li, W. (2022). Association between triglyceride–glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus. BMC Endocrine Disorders, 22(1), 261.Zheng, R. (2018). A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease. Lipids in Health and Disease, 17, 1–9.Khamseh, M. E. (2021). Triglyceride glucose index and related parameters (triglyceride glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and... Metabolic Syndrome and Related Disorders, 19(3), 167–173.Song, K. (2022). Comparison of the triglyceride glucose index and modified triglyceride glucose indices to predict nonalcoholic fatty liver disease in youths. The Journal of Pediatrics, 242, 79–85.e1.Kim, K.-S. (2022). Triglyceride and glucose index is a simple and easy-to-calculate marker associated with nonalcoholic fatty liver disease. Obesity, 30(6), 1279–1288.Lee, S. B. (2019). Triglyceride glucose index is superior to the homeostasis model assessment of insulin resistance for predicting nonalcoholic fatty liver disease in Korean adults. Endocrinology and Metabolism, 34(2), 179.Catanzaro, R. (2021). Triglycerides to high-density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease. Minerva Gastroenterology, 68(3), 261–268.Carlier, A. (2020). Dihydroceramides in triglyceride-enriched VLDL are associated with nonalcoholic fatty liver disease severity in type 2 diabetes. Cell Reports Medicine, 1(9).Chen, Z. (2019). Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid... Lipids in Health and Disease, 18, 1–7.Abdelbasset, W. K. (2019). A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life... Medicine, 98(12), e14918.Cheng, Y. (2023). Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease. Frontiers in Endocrinology, 14, 1098078.Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., et al. (2003). Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 37, 917–923.Kotronen, A., & Yki-Järvinen, H. (2008). Fatty liver: A novel component of the metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 27–38.Huang, Y., Bi, Y., Xu, M., Ma, Z., Xu, Y., Wang, T., Li, M., Liu, Y., Lu, J., Chen, Y., Huang, F., Xu, B., Zhang, J., Wang, W., Li, X., & Ning, G. (2012). Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(9), 2321–2326.Angulo, P. (2002). Nonalcoholic fatty liver disease. The New England Journal of Medicine, 346(16), 1221–1231.